There are several receptors and pathways associated with the development of pancreatic ductal adenocarcinoma (PDAC), including the EGFR, the receptor protein tyrosine kinase, the NOTCH signaling system, the ERBB2, and the TGF bate pathway. This evidence concerns the gene ERBB2 and pancreatic ductal adenocarcinoma.